Savoirs
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
Lyons, Larson, Gandhi Sunil, Liu Delong, Matei Carmen, Scott Bart, Hu Kuolung, Wang, Yang